The new tests for autism are not yet reliable enough to be offered commercially. None of the tests has gone through large ...
Proposed acquisition will add new anatomic pathology services, proprietary PCR tests and a national client base EL MONTE, Calif., December 22, 2025--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: ...
Hotels ranked on industry awards, guest reviews and hotel class ratings Unbiased content created by U.S. News editors Photo tours of select hotels by local experts Navigate forward to interact with ...
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”), a technology-based company with a well-established laboratory services business and a therapeutic development ...
Hosted on MSN
Two people found dead in Bothell mobile home fire
The Bothell Fire Department says that two people were found dead in a house fire on Saturday evening. Fire crews found the two dead after fighting a fire in a structure that was fully engulfed at the ...
When Cayden Chambers was born seven weeks premature in July of 2022, his parents, Mairin Jameson and Trystan Chambers, expected minor challenges related to his early arrival and kidney issues. What ...
Games will be carried over-the-air in the Seattle region on TEGNA's KONG, with at least 15 games simulcast on TEGNA's NBC affiliate, KING 5. Fans outside of Seattle will see the games on TEGNA ...
Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders.
It’s a tough market for talent. The companies on our annual list deliver lessons on how to compete, with benefits and much more. See our methodology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results